AndreaBozzo/ceres-open-data-index huggingface dataset:
Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats

Background
          Avascular necrosis of bone (osteonecrosis) can cause structural failure and subsequent deformation, leading to joint dysfunction and pain. Structural failure is the result of resorption of necrotic bone during revascularization, before new bone has formed or consolidated enough for loadbearing. Bone resorption can be reduced by bisphosphonates. If resorption of the necrotic bone could be reduced during the revascularization phase until sufficient new bone has formed, it would appear that structural failure could be avoided.
        
        
          Methods
          To test whether resorption of necrotic bone can be prevented, structural grafts were subjected to new bone ingrowth during systemic bisphosphonate treatment in a rat model.
        
        
          Results
          In rats treated with alendronate the necrotic bone was not resorbed, whereas it was almost entirely resorbed in the controls.
        
        
          Conclusion
          Systemic alendronate treatment prevents resorption of necrotic bone during revascularization. In patients with osteonecrosis, bisphosphonates may therefore prevent collapse of the necrotic bone.
Compound 529884: Ethane, 1,2-bis-(2-pyrazinyl)

Chemical compound data from PubChem database. IUPAC Name: 2-(2-pyrazin-2-ylethyl)pyrazine. Molecular Formula: C10H10N4. Molecular Weight: 186.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527384: 22,26-Dimethyl-hentriacontyl cyanide

Chemical compound data from PubChem database. IUPAC Name: 23,27-dimethyldotriacontanenitrile. Molecular Formula: C34H67N. Molecular Weight: 489.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400333-T1: [Translated] METHOD FOR MAKING A SNOWBOARD HAVING A RIGID ELEMENT ON ITS SURFACE

In the production of a sliding board, consisting of a basic structure (3) with an upper face of polymer (I) to which rigid polymer-based element(s) (2) is/are attached, (a) the lower surface of the rigid element is of a textile complex (1) having a textile core containing conductive threads (11, 12) and an outer layer compatible with (I) and (b) the element is pressed onto the structure while passing a current through the conductive threads to cause softening and welding.
Compound 525532: (3-Methoxy-4-hexyloxy-phenyl)-acetic acid, methyl ester

Chemical compound data from PubChem database. IUPAC Name: methyl 2-(4-hexoxy-3-methoxyphenyl)acetate. Molecular Formula: C16H24O4. Molecular Weight: 280.36. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525141: Dicycloheptyl phthalate

Chemical compound data from PubChem database. IUPAC Name: dicycloheptyl benzene-1,2-dicarboxylate. Molecular Formula: C22H30O4. Molecular Weight: 358.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Femoral vein size in newborns and infants: preliminary
		  investigation

Background:
          The femoral vein is an important site for central venous access in
				newborns and infants. The objectives of this study are to determine whether age
				or weight can be used clinically to predict the size of the femoral vein in
				newborns and infants, and to compare the size of the vein in each individual in
				both the supine and reverse Trendelenburg positions.
        
        
          Results:
          Analysis was done in 24 euvolemic individuals, each studied in
				both the supine and reverse Trendelenburg positions. Twelve of these
				individuals were newborns and 12 were infants. We used two-factor analysis of
				variance to explore differences between groups and multiple linear regression
				analysis to estimate the strength of the relationship between variables. In the
				infant group, there was a correlation between femoral vein diameter and weight.
				There was no correlation between weight and vessel size in newborns. In both
				the newborn and infant groups, vessel diameter increased with subjects in the
				reverse Trendelenburg position (P < 0.01).
        
        
          Conclusion:
          Weight is predictive of femoral vein diameter in infants, but not
				in newborns. In infants, weight might serve as a more sensitive index for
				estimating size of the femoral vein in order to determine accurately the size
				of intravascular catheter appropriate for cannulation. The diameter of the
				femoral vein increases in the reverse Trendelenburg position compared with that
				in the supine position in both newborns and infants. A large prospective study
				is required to validate these findings.
Genomic comparisons among

Background
          Insertion Sequence (IS) elements are mobile genetic elements widely distributed among bacteria. Their activities cause mutations, promoting genetic diversity and sometimes adaptation. Previous studies have examined their copy number and distribution in Escherichia coli K-12 and natural isolates. Here, we map most of the IS elements in E. coli B and compare their locations with the published genomes of K-12 and O157:H7.
        
        
          Results
          The genomic locations of IS elements reveal numerous differences between B, K-12, and O157:H7. IS elements occur in hok-sok loci (homologous to plasmid stabilization systems) in both B and K-12, whereas these same loci lack IS elements in O157:H7. IS elements in B and K-12 are often found in locations corresponding to O157:H7-specific sequences, which suggests IS involvement in chromosomal rearrangements including the incorporation of foreign DNA. Some sequences specific to B are identified, as reported previously for O157:H7. The extent of nucleotide sequence divergence between B and K-12 is <2% for most sequences adjacent to IS elements. By contrast, B and K-12 share only a few IS locations besides those in hok-sok loci. Several phenotypic features of B are explained by IS elements, including differential porin expression from K-12.
        
        
          Conclusions
          These data reveal a high level of IS activity since E. coli B, K-12, and O157:H7 diverged from a common ancestor, including IS association with deletions and incorporation of horizontally acquired genes as well as transpositions. These findings indicate the important role of IS elements in genome plasticity and divergence.
ALW Care Coordination Agencies

ALW program eligibility for Medi-Cal members interested in enrolling in the ALW program is assessed by Care Coordination Agencies, which are providers within the ALW program. Care Coordination Agencies (CCA) are responsible for evaluating referrals to the ALW, performing assessments, and submitting enrollment packages for the ALW to DHCS.  Contact information for CCAs is available at the following link: <a href='https://www.dhcs.ca.gov/services/ltc/Pages/AssistedLivingWaiver.aspx' target='_blank' rel='nofollow ugc noopener noreferrer'>https://www.dhcs.ca.gov/services/ltc/Pages/AssistedLivingWaiver.aspx</a>. This dataset contains the , provider physical location, provider phone number, provider fax number, provider contact name, provider contact email address and provider website .
Compound 528888: Butobarbital M (oxo)

Chemical compound data from PubChem database. IUPAC Name: 5-ethyl-5-(2-oxobutyl)-1,3-diazinane-2,4,6-trione. Molecular Formula: C10H14N2O4. Molecular Weight: 226.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
COVID-19 State Profile Report - Wyoming

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
2015 CMHS Uniform Reporting System (URS) Table for Northern Mariana Islands

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Northern Mariana Islands.  The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Patent AT-E40046-T1: [Translated] DENTAL SYRINGE.

1. Syringe intended for the ultra-ligamentary injection of liquid products, especially anaesthetic products, of the type composed of a body the forward portion of which, to which the injection needle is fitted, serves as housing for a container of the said liquid product, constituted by a glass tube the rear extremity of which is closed by a plug (7) of rubber or analogous material, while the rear portion of the body serves as guide for a piston (6) actuated by a rack (4), in such manner that when the operator operates the syringe, the piston progresses forward step by step, thrusting the said plug forward into the interior of the container, and consequently the liquid product into the injection needle, the piston (6) being terminated, at its forward extremity, by a head (12, 12') of a diameter substantially equal to the internal diameter of the container (8), characterised in that the head forwardly presents a concavity causing migration of the material of the plug (7) towards the axis in the advance of the piston (6).
Wisconsin: 2011-2012 NSDUH

This report presents Wisconsin\'s estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 528584: Bis[tert-butyl(dimethyl)silyl] 2-methylsuccinate

Chemical compound data from PubChem database. IUPAC Name: bis[tert-butyl(dimethyl)silyl] 2-methylbutanedioate. Molecular Formula: C17H36O4Si2. Molecular Weight: 360.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Child Care and Development Fund (CCDF) Statistics

The Child Care and Development Fund statistics are compiled through data reported by States and Territories on the ACF-800--Annual Aggregate Child Care Data Report and ACF-801—Monthly Child Care Data Report. 

<b>Units of Response: </b>CCDF Agencies 

<b>Type of Data: </b>Administrative 

<b>Tribal Data: </b>No 

<b>Periodicity: </b>Annual 

<b>Demographic Indicators: </b>Disability;Ethnicity;Housing Status;Race

<b>SORN: </b>Not Applicable 

<b>Data Use Agreement: </b>Unavailable 

<b>Data Use Agreement Location: </b>Unavailable 

<b>Granularity: </b>State;U.S. Territory 

<b>Spatial: </b>United States 

<b>Geocoding: </b>State
Compound 527283: Citronellyl isoheptanoate

Chemical compound data from PubChem database. IUPAC Name: 3,7-dimethyloct-6-enyl 5-methylhexanoate. Molecular Formula: C17H32O2. Molecular Weight: 268.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Actions Required for 2022 State Submissions of APSR Updates; CAPTA State Plan Updates; and Parts I, II, and III of the CFS-101

This Program Instruction (PI) provides guidance to states, territories, and insular areas (hereafter “states,” unless otherwise noted) on actions they are required to take to receive their allotments for Federal Fiscal Year (FY)1 2023 (subject to the availability of appropriations) authorized under title IV-B, subparts 1 and 2, section 106 of CAPTA, Chafee and ETV programs.

PI-22-01 (PDF)

Fiscal Year 2021 Allotments to States, Territories and Insular Areas Title IV-B, Subpart 1 Step Stephanie Tubbs Jones Child Welfare Services
Fiscal Year 2021 Allotments to States, Territories, and Insular Areas Title IV-B, Subpart 2 Promoting Safe and Stable Families (PSSF) Grant
Fiscal Year 2021 Supplemental Allotments to States and Territories MaryLee Allen Promoting Safe and Stable Families Program
Fiscal Year 2021 Allotments to State, Territories and Insular Areas Monthly Caseworker Visit Formula Grants
Fiscal Year 2021 Allotments to States and Indian Tribes\Tribal Organizations Title IV-B Kinship Navigator Funds
Fiscal Year 2021 Allotments to States and Indian Tribes\Tribal Organizations John H. Chafee Foster Care Program for Successful Transition to Adulthood
Fiscal Year 2021 Allotments to States and Indian Tribes\Tribal Organizations John H. Chafee Foster Care Program Education and Training Voucher (CETV Grants)
Fiscal Year 2021 Additional Allotments to States and Tribes John H. Chafee Foster Care Program Education and Training Vouchers
Fiscal Year 2021 Allotments to States, Territories and Insular Areas Child Abuse Prevention and Treatment Act (CAPTA) State Grants
Fiscal Year 2021 Supplemental Allotments to States and Territories Child Abuse Prevention and Treatment Act (CAPTA)
Fiscal Year 2020 Allotments to States, Territories and Insular Areas Family First Prevention Services Act Transition Grant Funding

CFS-101 Instructions, Part I, II, and III

Introduction
Part I Instructions: Annual Budget Request for Funds under Title IV-B, Subparts 1 & 2, CAPTA State Grant, Chafee, and ETV
Part II Instructions: Annual Estimated Expenditure Summary of Child and Family Services Funds
Part III Instructions: Expenditures for Title IV-B, Subparts 1 and 2, John H. Chafee Foster Care Program for Successful Transition to Adulthood, and Education and Training Voucher (ETV) Program

CFS-101 Forms, Parts I, II and III Excel Workbook (XLSX)

CFS-101 Forms Part I
CFS-101 Forms Part II
CFS-101 Forms Part III

Annual Reporting of Education and Training Vouchers Awarded

Metadata-only record linking to the original dataset. Open original dataset below.
4.15b Facility licensing, certification, or accreditation, by facility operation and primary focus of facility: 2010. Percent

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing facility licensing, certification, or accreditation, by facility operation and primary focus of facility in 2010. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Compound 530490: m-Anisic acid, dodec-9-ynyl ester

Chemical compound data from PubChem database. IUPAC Name: dodec-9-ynyl 3-methoxybenzoate. Molecular Formula: C20H28O3. Molecular Weight: 316.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Provider Network Data: 2021 Quarter 4

This Provider Network Data contains information on individual and institutional providers participating in health plan networks from October through December 2021. Plan network data is collected from Medicaid, Commercial, and Exchange plans on a quarterly basis by the Department of Health, including managed care plans, as well as PPO/EPO plans.

For more information, please visit: <a href=https://pndslookup.health.ny.gov>https://pndslookup.health.ny.gov</a>
Patent AR-114334-A1: [Translated] METHOD TO REPAIR HAIR SUBJECTED TO OXIDANT TREATMENTS

[Translated] A method of repairing hair that has been subjected to oxidative treatments, the methods comprising the sequential steps of: (i) soaking the hair in an aqueous treatment composition, (ii) rinsing the hair of step (i); characterized in that the aqueous treatment composition comprises 0.1 to 6% by weight of N-acetyl amino acid, based on the total weight of the composition, where the N-acetyl amino acid is selected from the group consisting of N-acetyl glycine , N-acetyl alanine, N-acetyl proline, N-acetyl leucine, N-acetyl isoleucine, N-acetyl valine, N-acetyl tyrosine, N-acetyl phenylalanine, N-acetyl tryptophan, N-acetyl serine, N-acetyl glutamine , N-acetyl threonine, N-acetyl asparagine, N-acetyl methionine, N-acetyl lysine, N-acetyl histidine and their mixtures, provide damage repair benefits.
Articular cartilage and changes in arthritis: Noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage

Cartilage contains numerous noncollagenous proteins in its extracellular matrix, including proteoglycans. At least 40 such molecules have been identified, differing greatly in structure, distribution, and function. Some are present in only selected cartilages or cartilage zones, some vary in their presence with a person's development and age, and others are more universal in their expression. Some may not even be made by the chondrocytes, but may arise by absorption from the synovial fluid. In many cases, the molecules' function is unclear, but the importance of others is illustrated by their involvement in genetic disorders. This review provides a selective survey of these molecules and discusses their structure, function, and involvement in inherited and arthritic disorders.
2010 CMHS Uniform Reporting System (URS) Output Tables for Connecticut

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
NCHS - Death rates and life expectancy at birth

This dataset of U.S. mortality trends since 1900 highlights the differences in age-adjusted death rates and life expectancy at birth by race and sex.

Age-adjusted death rates (deaths per 100,000) after 1998 are calculated based on the 2000 U.S. standard population. Populations used for computing death rates for 2011–2017 are postcensal estimates based on the 2010 census, estimated as of July 1, 2010. Rates for census years are based on populations enumerated in the corresponding censuses. Rates for noncensus years between 2000 and 2010 are revised using updated intercensal population estimates and may differ from rates previously published. Data on age-adjusted death rates prior to 1999 are taken from historical data (see References below).

Life expectancy data are available up to 2017. Due to changes in categories of race used in publications, data are not available for the black population consistently before 1968, and not at all before 1960. More information on historical data on age-adjusted death rates is available at https://www.cdc.gov/nchs/nvss/mortality/hist293.htm.

SOURCES

CDC/NCHS, National Vital Statistics System, historical data, 1900-1998 (see https://www.cdc.gov/nchs/nvss/mortality_historical_data.htm); CDC/NCHS, National Vital Statistics System, mortality data (see http://www.cdc.gov/nchs/deaths.htm); and CDC WONDER (see http://wonder.cdc.gov).

REFERENCES

1. National Center for Health Statistics, Data Warehouse. Comparability of cause-of-death between ICD revisions. 2008. Available from: http://www.cdc.gov/nchs/nvss/mortality/comparability_icd.htm.

2. National Center for Health Statistics. Vital statistics data available. Mortality multiple cause files. Hyattsville, MD: National Center for Health Statistics. Available from: https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm.

3. Kochanek KD, Murphy SL, Xu JQ, Arias E. Deaths: Final data for 2017. National Vital Statistics Reports; vol 68 no 9. Hyattsville, MD: National Center for Health Statistics. 2019. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_09-508.pdf.

4. Arias E, Xu JQ. United States life tables, 2017. National Vital Statistics Reports; vol 68 no 7. Hyattsville, MD: National Center for Health Statistics. 2019. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_07-508.pdf.

5. National Center for Health Statistics. Historical Data, 1900-1998. 2009. Available from: https://www.cdc.gov/nchs/nvss/mortality_historical_data.htm.
Compound 528099: Hexanoic acid, DMTBS

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] hexanoate. Molecular Formula: C12H26O2Si. Molecular Weight: 230.42. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530683: 4-Ethylbenzoic acid, hex-4-yn-3-yl ester

Chemical compound data from PubChem database. IUPAC Name: hex-4-yn-3-yl 4-ethylbenzoate. Molecular Formula: C15H18O2. Molecular Weight: 230.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Fostering Readiness and Permanency Project (FRP) Permanency Innovations Initiative (PII) Grantee Profile

The Arizona Department of Economic Security, Central Region (Eastern Maricopa and Pinal Counties) has developed the Fostering Readiness and Permanency Project (FRP) which uses coordinated service provision to prepare children who have been in or are most likely to remain in continuous out-of-home care and their potential caregivers for permanency.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E399572-T1: [Translated] CATHETER BALLOON

The invention relates to a balloon for medical devices, in particular for catheters used in angioplasty, comprising a polyamide copolymer material characterized in that said polyamide copolymer material is represented by the general formula (I): HO—(PF—OOC—PA-COO—PF—COO—PA)n-COOH in which PA is a polyamide segment and PF is a diol segment comprising dimer diols and/or corresponding OH-terminating diol polyesters and n is a number between 5 and 20.